Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS Blood and Transplant (NHSBT) |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £50,000 |
Awarded to
| Award value: | £111,000 |
| Award decision date: | 6 April 2022 |
| Award status: | Active |
NHSBT's Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
3 June 2020
Closed
Estimated Value
£50,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Release Date: | 13 April 2022 |
| Application Deadline: | 3 June 2020 |
| Contract Start Date: | 6 April 2022 |
| Contract End Date: | 5 April 2024 |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-b5fd17-3fd467a5-e5f9-42c6-9584-4a41fa5faa04 |
| Notice Reference: | 4e846bf1-37bd-4aca-8807-356ca5ac9b40-528427 |
View Original Notice
Access the full notice on the official portal